Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Candidiasis Recurrent”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)Study completedNCT03840616
What this trial is testing

Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 219
Large-scale testing (Phase 3)Study completedNCT03562156
What this trial is testing

Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 438
Testing effectiveness (Phase 2)Ended earlyNCT00199264
What this trial is testing

Efficacy Vulvovaginitis Candida

Who this might be right for
Candidiasis Vulvaginitis
J. Uriach and Company 60
Large-scale testing (Phase 3)Study completedNCT04029116
What this trial is testing

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Scynexis, Inc. 440
Not applicableNot Yet RecruitingNCT05289375
What this trial is testing

Efficacy of the Vacucis Candida® Autovaccine

Who this might be right for
Oral CandidiasisOral Candidiasis RecurrentRadiotherapy; Complications+3 more
University of Santiago de Compostela 46
Post-approval studies (Phase 4)Study completedNCT00000951
What this trial is testing

Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush

Who this might be right for
Candidiasis, OralHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 948
Not applicableUnknownNCT05895162
What this trial is testing

Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.

Who this might be right for
Vulvovaginal CandidiasisVaginal Yeast Infections
FEMPHARMA Kft. 76
Large-scale testing (Phase 3)UnknownNCT04734405
What this trial is testing

A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
ProFem GmbH 432
Large-scale testing (Phase 3)Study completedNCT03561701
What this trial is testing

Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Mycovia Pharmaceuticals Inc. 425
Testing effectiveness (Phase 2)Study completedNCT02267382
What this trial is testing

Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

Who this might be right for
Recurrent Vulvovaginal Candidiasis
Viamet 254